A detailed history of South Street Advisors LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, South Street Advisors LLC holds 186,531 shares of NVO stock, worth $20.1 Million. This represents 3.38% of its overall portfolio holdings.

Number of Shares
186,531
Previous 231,519 19.43%
Holding current value
$20.1 Million
Previous $33 Million 32.79%
% of portfolio
3.38%
Previous 5.01%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$119.07 - $145.42 $5.36 Million - $6.54 Million
-44,988 Reduced 19.43%
186,531 $22.2 Million
Q2 2024

Aug 07, 2024

SELL
$122.71 - $146.91 $393,776 - $471,434
-3,209 Reduced 1.37%
231,519 $33 Million
Q1 2024

May 10, 2024

SELL
$102.11 - $135.92 $520,658 - $693,056
-5,099 Reduced 2.13%
234,728 $30.1 Million
Q4 2023

Feb 14, 2024

SELL
$87.78 - $105.45 $82,776 - $99,439
-943 Reduced 0.39%
239,827 $24.8 Million
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $11 Million - $24.2 Million
121,406 Added 101.71%
240,770 $21.9 Million
Q2 2023

Aug 11, 2023

SELL
$155.98 - $172.65 $5.18 Million - $5.74 Million
-33,239 Reduced 21.78%
119,364 $19.3 Million
Q1 2023

May 15, 2023

BUY
$132.34 - $159.14 $12,439 - $14,959
94 Added 0.06%
152,603 $24.3 Million
Q4 2022

Feb 06, 2023

SELL
$102.55 - $135.33 $395,637 - $522,103
-3,858 Reduced 2.47%
152,509 $20.6 Million
Q3 2022

Nov 03, 2022

SELL
$95.28 - $116.93 $224,384 - $275,370
-2,355 Reduced 1.48%
156,367 $15.6 Million
Q2 2022

Aug 09, 2022

BUY
$103.24 - $121.81 $6.85 Million - $8.08 Million
66,305 Added 71.75%
158,722 $17.7 Million
Q1 2022

May 16, 2022

BUY
$93.1 - $112.54 $8.6 Million - $10.4 Million
92,417 New
92,417 $10.3 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $244B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track South Street Advisors LLC Portfolio

Follow South Street Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of South Street Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on South Street Advisors LLC with notifications on news.